1 tibody engineering could lead to a universal antibody capable of neutralizing all three serotypes of

2  Intratracheal administration of Wnt3a or an antibody capable of neutralizing Dkk1 inhibited neutroph

3 tified and affinity-maturated the first scFv antibody capable of inhibiting FAP function.

4  To test this theory, a humanized monoclonal antibody capable of neutralizing human amphiregulin was

5  AML cells, we generated an IL1RAP-targeting antibody capable of blocking IL-1 signaling and show tha

6 is an internalizing anti-Trop-2 pancarcinoma antibody capable of targeting most epithelial cancers.

7 tion time, we have identified a human domain antibody capable of mediating selective localization of

8      Thus, all detectable anti-DNA idiotypic antibody capable of blocking SLE anti-DNA combining site

9 utralization by PA41, a humanized monoclonal antibody capable of neutralizing TcdB from a diverse arr

10                    In addition, a monoclonal antibody capable of inhibiting the function of P-gp was

11 lture can be inhibited by the presence of an antibody capable of neutralizing the biological activity

12 body variable domain (scFv) and a monoclonal antibody capable of binding to an Adda-group (3-amino-9-

13                              Vaccine-induced antibody capable of enhancing transcytosis in vitro via